Common Stock, Shares, Outstanding of Blueprint Medicines Corp from 31 Dec 2014 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Blueprint Medicines Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Mar 2025.
  • Blueprint Medicines Corp Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2025 was 64,563,911, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Blueprint Medicines Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 64,563,911 +1,969,664 +3.1% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 63,712,256 +2,565,020 +4.2% 31 Dec 2024 10-Q 01 May 2025 2025 Q1
Q3 2024 63,454,673 +2,713,929 +4.5% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 63,165,725 +2,527,450 +4.2% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 62,594,247 +2,177,912 +3.6% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 61,147,236 +1,188,317 +2% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 60,740,744 +932,252 +1.6% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 60,638,275 +949,980 +1.6% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 60,416,335 +860,361 +1.4% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 59,958,919 +817,833 +1.4% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 59,808,492 +2,014,959 +3.5% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 59,688,295 +1,133,736 +1.9% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 59,555,974 +1,278,562 +2.2% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 59,141,086 +1,347,553 +2.3% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 57,793,533 +3,279,138 +6% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 58,554,559 +4,270,058 +7.9% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 58,277,412 +4,108,879 +7.6% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 57,793,533 +8,521,310 +17% 31 Dec 2020 10-K 17 Feb 2022 2021 FY
Q3 2020 54,514,395 +5,338,973 +11% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 54,284,501 +5,224,857 +11% 30 Jun 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 54,168,533 +9,997,068 +23% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 49,272,223 +5,235,197 +12% 31 Dec 2019 10-K 17 Feb 2021 2020 FY
Q3 2019 49,175,422 +5,230,106 +12% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 49,059,644 +5,175,870 +12% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 44,171,465 +350,218 +0.8% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 44,037,026 +459,500 +1.1% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 43,945,316 +4,766,297 +12% 30 Sep 2018 10-Q 30 Oct 2018 2018 Q3
Q2 2018 43,883,774 +4,803,622 +12% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 43,821,247 +10,571,887 +32% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 43,577,526 +10,454,172 +32% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 39,179,019 +11,885,096 +44% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 39,080,152 +11,852,737 +44% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 33,249,360 +6,107,767 +23% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 33,123,354 +6,057,796 +22% 31 Dec 2016 10-K 21 Feb 2018 2017 FY
Q3 2016 27,293,923 +398,334 +1.5% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 27,227,415 +535,469 +2% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 27,141,593 +25,410,156 +1468% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 27,065,558 +25,438,820 +1564% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q3 2015 26,895,589 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 26,691,946 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 1,731,437 31 Mar 2015 10-Q 11 Jun 2015 2015 Q1
Q4 2014 1,626,738 31 Dec 2014 10-K 11 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.